Welcome...

...to the Multiple Sclerosis Pro website, a comprehensive resource center for clinicians who treat MS. Read more

Featured

Complementary and Alternative Medicine in MS: Guiding Our Patients
Mark C. Cascione, MD

A review of the literature shows that many patients with multiple sclerosis (MS) have turned to the use of complementary and alternative medicines (CAM).1-3 As a neurologist who specializes in the treatment of patients with MS, I receive frequent questions about alternative therapies from many of the patients I treat. As healthcare providers, we have a responsibility to guide our patients; however, most of us know little or nothing about CAM therapies. This makes sense, since there are few randomized controlled trials (RCTs) of CAM therapies in MS.

Read More

Expert Q&A

We encourage you to submit your questions on multiple sclerosis treatment and care to our Steering Committee. We post selected questions and corresponding answers. Read more

Has early treatment of MS with a disease-modifying therapy (DMT) been shown to improve or preserve cognitive function?

What diseases are considered in the differential diagnosis of MS? Are there any guidelines or consensus statements published on this topic?

Take the Poll

On the Wire

MS Physician News

Magnetic Resonance Imaging Examined in Multiple Sclerosis

The use of functional MRI to assess patterns of brain activation in adults and children with multiple sclerosis may offer insight into disease progression among these groups, according to research published in the February issue of Radiology.

Read More
General Neurology Physician News

FDA Warns of Link Between Natalizumab, Brain Infection

On Feb. 5, the U.S. Food and Drug Administration notified health care professionals and patients that the risk of developing a rare but serious brain infection increases as the number of natalizumab (Tysabri) infusions received increases.

Read More
MS News for Your Patient

More Doses of MS Drug Raise Risk of Brain Infection

FDA adds new warning on Tysabri label, but says benefits still outweigh dangers.

Read More